Indicated for the use with magnetic resonance imaging (MRI) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. Has been shown to facilitate visualization of intracranial lesions including but not limited to tumors.
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.